Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTXS
1726
CALL
DELISTED
Citrix Systems Inc
CTXS
| $4.86M | ﹤0.01% |
+51,400
| New | +$4.69M |
|
|
FLNA
1727
Filana Therapeutics
FLNA
$48.8M
| $4.85M | ﹤0.01% |
111,008
+54,207
| +95% | +$2.84M |
|
1728
Simply Good Foods
SMPL
$1.01B
| $4.83M | ﹤0.01% |
116,084
+29,412
| +34% | +$1.12M |
|
|
GMS
1729
DELISTED
GMS Inc
GMS
| $4.83M | ﹤0.01% |
80,282
+11,958
| +18% | +$645K |
|
1730
PUT
KLA
KLAC
$255B
| $4.82M | ﹤0.01% |
112,000
-113,000
| -50% | -$4.36M |
|
1731
Cytokinetics
CYTK
$10.7B
| $4.81M | ﹤0.01% |
105,589
+22,295
| +27% | +$860K |
|
1732
Cogent Communications
CCOI
$669M
| $4.81M | ﹤0.01% |
65,735
+21,304
| +48% | +$1.6M |
|
|
JJC
1733
DELISTED
iPath Series B Bloomberg Copper Subindex Total ReturnSM ETN
JJC
| $4.8M | ﹤0.01% |
215,000
| – | – |
|
|
GOGL
1734
DELISTED
Golden Ocean Group
GOGL
| $4.79M | ﹤0.01% |
515,653
-890,267
| -63% | -$8.08M |
|
1735
Piper Sandler
PIPR
$5.23B
| $4.78M | ﹤0.01% |
107,120
+20,728
| +24% | +$881K |
|
|
VBTX
1736
DELISTED
Veritex Holdings
VBTX
| $4.77M | ﹤0.01% |
119,891
+55,156
| +85% | +$2.23M |
|
|
MRTX
1737
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.76M | ﹤0.01% |
32,470
+17,374
| +115% | +$2.7M |
|
1738
ePlus
PLUS
$2.53B
| $4.76M | ﹤0.01% |
88,302
-13,250
| -13% | -$731K |
|
|
K
1739
PUT
DELISTED
Kellanova
K
| $4.74M | ﹤0.01% |
78,384
+35,784
| +84% | +$2.11M |
|
1740
RenaissanceRe
RNR
$13.4B
| $4.73M | ﹤0.01% |
27,947
-70,100
| -71% | -$11M |
|
|
ROIC
1741
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $4.73M | ﹤0.01% |
241,395
+31,449
| +15% | +$579K |
|
1742
International Bancshares
IBOC
$4.75B
| $4.72M | ﹤0.01% |
111,355
+31,161
| +39% | +$1.34M |
|
|
BRFS
1743
DELISTED
BRF SA
BRFS
| $4.72M | ﹤0.01% |
1,153,554
+178,110
| +18% | +$727K |
|
1744
JELD-WEN Holding
JELD
$154M
| $4.7M | ﹤0.01% |
178,222
+58,106
| +48% | +$1.51M |
|
|
NXDT
1745
NexPoint Diversified Real Estate Trust
NXDT
$237M
| $4.7M | ﹤0.01% |
204,075
| – | – |
|
|
BIG
1746
DELISTED
Big Lots, Inc.
BIG
| $4.7M | ﹤0.01% |
104,204
+55,379
| +113% | +$2.52M |
|
1747
Moog Inc Class A
MOG.A
$13B
| $4.7M | ﹤0.01% |
57,982
+8,471
| +17% | +$657K |
|
1748
Federal Signal
FSS
$8.07B
| $4.69M | ﹤0.01% |
108,191
+8,915
| +9% | +$387K |
|
|
ERF
1749
DELISTED
Enerplus Corporation
ERF
| $4.68M | ﹤0.01% |
442,842
+168,806
| +62% | +$1.64M |
|
1750
Royal Gold
RGLD
$17.5B
| $4.68M | ﹤0.01% |
44,492
-62,661
| -58% | -$6.32M |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.